Premium
Lamotrigine fails to show effectiveness in borderline personality disorder trial
Publication year - 2018
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30341
Subject(s) - lamotrigine , borderline personality disorder , anticonvulsant , placebo , medicine , psychiatry , personality , clinical psychology , clinical trial , psychology , epilepsy , alternative medicine , social psychology , pathology
A placebo‐controlled trial has found no significant improvement at 52 weeks from use of lamotrigine in a group of patients with borderline personality disorder. The results contrast with those of earlier smaller trials that suggested some benefit from use of the anticonvulsant. Study results were published online April 6 in the American Journal of Psychiatry .